safingol has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ding, L; Dong, P; Jiang, M; Shi, H; Wen, S; Yang, J; Yang, Y; Zhu, Y | 1 |
| Adeli, K; Baker, C; Dekker, MJ; Naples, M; Qiu, W; Sacco, J; Samsoondar, J; Zhang, R | 1 |
2 other study(ies) available for safingol and Dyslipidemia
| Article | Year |
|---|---|
Atherosclerotic dyslipidemia revealed by plasma lipidomics on ApoE
Topics: Animals; Atherosclerosis; Biomarkers; Chromatography, High Pressure Liquid; Diet, High-Fat; Discriminant Analysis; Disease Models, Animal; Disease Progression; Dyslipidemias; Genetic Predisposition to Disease; Lipids; Male; Mass Spectrometry; Metabolomics; Mice, Inbred C57BL; Mice, Knockout, ApoE; Pattern Recognition, Automated; Phenotype; Phosphatidylcholines; Plaque, Atherosclerotic; Sphingomyelins; Sphingosine | 2017 |
Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Topics: Animal Feed; Animals; Apolipoprotein B-100; Cricetinae; Dietary Fats; Disease Models, Animal; Dyslipidemias; Fatty Acids, Monounsaturated; Fructose; Glucose Intolerance; Hepatitis; Immunosuppressive Agents; Insulin Resistance; Lipoproteins, VLDL; Liver; Male; Mesocricetus; Signal Transduction; Sphingolipids; Sphingosine | 2013 |